Nacho Abia

I am honored to be the Chief Executive Officer and a member of the Board of Directors at Grifols, a global healthcare company and leading provider of plasma-derived medicines with 115 years of innovation in healthcare services and solutions. With over 25 years of international management experience at publicly traded life-science and medical-technology companies, I’m proud to focus my energies today on accelerating the Grifols growth story and furthering its operational excellence as we work to deliver more medicines to more patients in more parts of the world. At Grifols, the mission of our more than 24.000 employees is simple: to improve the health and well-being of patients around the world. We believe that we’ve only just begun to scratch the surface of plasma’s enormous potential. More Grifols innovation is on the way to enhance people’s quality of life. I’m excited about this company’s future and I’m looking forward to all the advancements we will achieve in the years to come. About Grifols Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people around the world. The company develops, produces, and provides innovative healthcare services and solutions in more than 110 countries. A pioneer in the plasma industry, Grifols develops innovative plasma-derived medicines and other biopharmaceutical solutions that treat patients with chronic, rare and, at times, life-threatening conditions. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology and hematology, neurology, and infectious diseases. Grifols has the largest network of donation centers in the world, with more than 390 across North America, Europe, Africa and the Middle East, and China. As a recognized leader in transfusion medicine, Grifols offers a comprehensive portfolio of solutions designed to enhance safety from donation to transfusion, in addition to clinical diagnostic technologies. Grifols also supplies tools, information systems, and services that enable hospitals, pharmacies, and healthcare professionals to efficiently deliver expert medical care. Grifols, with more than 24,000 employees in more than 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety, and ethical leadership. For more information, please visit www.grifols.com